Cargando…

Risk Factors Associated with Post-therapeutic Outcome for Medulloblastoma: An Experience from Indonesia

CONTEXT: The prognosis of medulloblastoma is better in patients who underwent complete treatment consisting of surgery, radiotherapy, and chemotherapy. However, the realization of such multidiscipline management is quite challenging in developing countries, including Indonesia. Until now, no study o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandian, David, Harlyjoy, Alphadenti, Nugroho, Setyo Widi, Ichwan, Syaiful
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477848/
https://www.ncbi.nlm.nih.gov/pubmed/34660359
http://dx.doi.org/10.4103/ajns.AJNS_490_20
_version_ 1784575930871578624
author Tandian, David
Harlyjoy, Alphadenti
Nugroho, Setyo Widi
Ichwan, Syaiful
author_facet Tandian, David
Harlyjoy, Alphadenti
Nugroho, Setyo Widi
Ichwan, Syaiful
author_sort Tandian, David
collection PubMed
description CONTEXT: The prognosis of medulloblastoma is better in patients who underwent complete treatment consisting of surgery, radiotherapy, and chemotherapy. However, the realization of such multidiscipline management is quite challenging in developing countries, including Indonesia. Until now, no study on the management of medulloblastoma has ever been conducted in Indonesia. AIMS: The authors aimed to study the characteristics, management, and mortality outcome of medulloblastoma patients in Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia. SUBJECTS AND METHODS: This study was based on medical record and registry of 44 medulloblastoma patients who underwent tumor removal in Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia, between 2011 and 2018. STATISTICAL ANALYSIS USED: Cox regression analysis was utilized to determine the relationship between patients' demography, tumor characteristics, and treatment, with mortality. RESULTS: The incidence of mortality was 84.1% and median months' survival time (95% confidence interval [CI]) was 13 (8.67–17.32). Gross total removal (GTR) was performed in 43.2% of all tumor removal surgery. Only 50% of all patients completed radiotherapy, and 6.8% concluded multimodalities treatment (surgery, radiotherapy, and chemotherapy). Significant statistical association between age, gender, and extent of resection with mortality was identified (HR [95% CI] for age: 0.44 [0.22–0.88], gender: 0.001 [0.000–0.27; REF: female], and biopsy: 31.52 [1.09–910.56; REF: GTR]). CONCLUSIONS: The survival rate of medulloblastoma in Indonesia is inferior to that previously reported in other studies. There is no unusual characteristic contributing to neoteric risk factor. The authors surmise that insufficient multidisciplinary management for the disease, consisting of suboptimal tumor resection, the absence of risk stratification, and incomplete postsurgical treatment (radiotherapy and chemotherapy) resulted in such outcome.
format Online
Article
Text
id pubmed-8477848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-84778482021-10-14 Risk Factors Associated with Post-therapeutic Outcome for Medulloblastoma: An Experience from Indonesia Tandian, David Harlyjoy, Alphadenti Nugroho, Setyo Widi Ichwan, Syaiful Asian J Neurosurg Original Article CONTEXT: The prognosis of medulloblastoma is better in patients who underwent complete treatment consisting of surgery, radiotherapy, and chemotherapy. However, the realization of such multidiscipline management is quite challenging in developing countries, including Indonesia. Until now, no study on the management of medulloblastoma has ever been conducted in Indonesia. AIMS: The authors aimed to study the characteristics, management, and mortality outcome of medulloblastoma patients in Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia. SUBJECTS AND METHODS: This study was based on medical record and registry of 44 medulloblastoma patients who underwent tumor removal in Dr. Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia, between 2011 and 2018. STATISTICAL ANALYSIS USED: Cox regression analysis was utilized to determine the relationship between patients' demography, tumor characteristics, and treatment, with mortality. RESULTS: The incidence of mortality was 84.1% and median months' survival time (95% confidence interval [CI]) was 13 (8.67–17.32). Gross total removal (GTR) was performed in 43.2% of all tumor removal surgery. Only 50% of all patients completed radiotherapy, and 6.8% concluded multimodalities treatment (surgery, radiotherapy, and chemotherapy). Significant statistical association between age, gender, and extent of resection with mortality was identified (HR [95% CI] for age: 0.44 [0.22–0.88], gender: 0.001 [0.000–0.27; REF: female], and biopsy: 31.52 [1.09–910.56; REF: GTR]). CONCLUSIONS: The survival rate of medulloblastoma in Indonesia is inferior to that previously reported in other studies. There is no unusual characteristic contributing to neoteric risk factor. The authors surmise that insufficient multidisciplinary management for the disease, consisting of suboptimal tumor resection, the absence of risk stratification, and incomplete postsurgical treatment (radiotherapy and chemotherapy) resulted in such outcome. Wolters Kluwer - Medknow 2021-09-14 /pmc/articles/PMC8477848/ /pubmed/34660359 http://dx.doi.org/10.4103/ajns.AJNS_490_20 Text en Copyright: © 2021 Asian Journal of Neurosurgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Tandian, David
Harlyjoy, Alphadenti
Nugroho, Setyo Widi
Ichwan, Syaiful
Risk Factors Associated with Post-therapeutic Outcome for Medulloblastoma: An Experience from Indonesia
title Risk Factors Associated with Post-therapeutic Outcome for Medulloblastoma: An Experience from Indonesia
title_full Risk Factors Associated with Post-therapeutic Outcome for Medulloblastoma: An Experience from Indonesia
title_fullStr Risk Factors Associated with Post-therapeutic Outcome for Medulloblastoma: An Experience from Indonesia
title_full_unstemmed Risk Factors Associated with Post-therapeutic Outcome for Medulloblastoma: An Experience from Indonesia
title_short Risk Factors Associated with Post-therapeutic Outcome for Medulloblastoma: An Experience from Indonesia
title_sort risk factors associated with post-therapeutic outcome for medulloblastoma: an experience from indonesia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477848/
https://www.ncbi.nlm.nih.gov/pubmed/34660359
http://dx.doi.org/10.4103/ajns.AJNS_490_20
work_keys_str_mv AT tandiandavid riskfactorsassociatedwithposttherapeuticoutcomeformedulloblastomaanexperiencefromindonesia
AT harlyjoyalphadenti riskfactorsassociatedwithposttherapeuticoutcomeformedulloblastomaanexperiencefromindonesia
AT nugrohosetyowidi riskfactorsassociatedwithposttherapeuticoutcomeformedulloblastomaanexperiencefromindonesia
AT ichwansyaiful riskfactorsassociatedwithposttherapeuticoutcomeformedulloblastomaanexperiencefromindonesia